SC 13G/A | 2010-02-11 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 5,747,550 | 18.2% | EDGAR |
SC 13G/A | 2010-02-09 | TUDOR INVESTMENT CORP ET AL | PROGENICS PHARMACEUTICALS INC | 2,107,881 | 6.7% | EDGAR |
SC 13G | 2010-01-29 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 1,852,911 | 5.8% | EDGAR |
SC 13G/A | 2009-06-10 | WELLINGTON MANAGEMENT CO LLP | PROGENICS PHARMACEUTICALS INC | 2,247,536 | 7.2% | EDGAR |
SC 13G/A | 2009-02-17 | WELLINGTON MANAGEMENT CO LLP | PROGENICS PHARMACEUTICALS INC | 4,017,754 | 13.2% | EDGAR |
SC 13G/A | 2009-02-17 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 4,500,391 | 14.8% | EDGAR |
SC 13G | 2009-02-17 | MORGAN STANLEY | PROGENICS PHARMACEUTICALS INC | 1,981,798 | 6.5% | EDGAR |
SC 13G/A | 2009-02-13 | SECTORAL ASSET MANAGEMENT INC | PROGENICS PHARMACEUTICALS INC | 3,923,325 | 12.9% | EDGAR |
SC 13G/A | 2009-02-09 | TUDOR INVESTMENT CORP ET AL | PROGENICS PHARMACEUTICALS INC | 2,107,881 | 7.1% | EDGAR |
SC 13G | 2009-02-05 | BARCLAYS GLOBAL INVESTORS NA /CA/ | PROGENICS PHARMACEUTICALS INC | 654,895 | 2.2% | EDGAR |
SC 13G | 2009-01-12 | PICTET & CIE EUROPE SA | PROGENICS PHARMACEUTICALS INC | 2 | 9.4% | EDGAR |
SC 13G/A | 2008-05-12 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 3,338,530 | 11.2% | EDGAR |
SC 13G/A | 2008-02-14 | WELLINGTON MANAGEMENT CO LLP | PROGENICS PHARMACEUTICALS INC | 3,727,581 | 12.6% | EDGAR |
SC 13G/A | 2008-02-13 | TUDOR INVESTMENT CORP ET AL | PROGENICS PHARMACEUTICALS INC | 2,107,881 | 7.1% | EDGAR |
SC 13G/A | 2008-02-13 | SECTORAL ASSET MANAGEMENT INC | PROGENICS PHARMACEUTICALS INC | 3,442,906 | 11.6% | EDGAR |
SC 13G/A | 2008-02-13 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 2,494,906 | 8.4% | EDGAR |
SC 13G/A | 2008-02-08 | DELAWARE MANAGEMENT HOLDINGS CO INC | PROGENICS PHARMACEUTICALS INC | 614,343 | 2.1% | EDGAR |
SC 13G | 2008-01-31 | PROGENICS PHARMACEUTICALS INC | PROGENICS PHARMACEUTICALS INC | 9 | 11.0% | EDGAR |
SC 13G/A | 2008-01-22 | BARCLAYS GLOBAL INVESTORS NA /CA/ | PROGENICS PHARMACEUTICALS INC | 502,185 | 1.7% | EDGAR |
SC 13G | 2007-09-10 | WELLINGTON MANAGEMENT CO LLP | PROGENICS PHARMACEUTICALS INC | 3,181,146 | 11.8% | EDGAR |